Contact Uscontact

Parc Euromédecine, Cap Gamma
1682 Rue de la Valsière - CS17383
34189 Montpellier cedex 4 - FRANCE

Office +33 (0)4 67 727 670
FAX : +33 (0)4 67 727 679

Out-LicensingOut-Licensing 

3 oncology-focused projects, including novel targeted therapies (molecules and antibodies), under development and potentially available for licensing or collaboration.
» Read more ...

Newsrss

04/25/13 : OriBase Pharma is entitled to taxes return for investment

Thanks to a first round of fund raising realized successfully ( 1 500 000€), involving 52 investors, we were able...
» Read more ...

04/10/13

OriBase Pharma is selected to present at BioTrinity 2013 Conference ( (Newbury 14-16 May 2013)

Biotrinity 2013

BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other European partnering conference.  80 investment firms are expected and 90 companies will be presenting in the showcase. OriBase Pharma has been selected to present its R&D projects at this largest annual biopartnering meeting in Europe.

 

We will be presenting in the Company Showcase at BioTrinity in Newbury on the 14-16th May 2013. If you would like to arrange a meeting with us, please request a meeting with us via the partnering system by registering at www.biotrinity.com.